1Dietrich G, Viret JF, Hess J. Mycobacterium bovis BCG-based vaccines against tuberculosis: novel developments. Vaccine, 2003,21:667-670.
2Orme IM. The latent tuberculosis bacillus( I'll let you know if ever meet one). Int J Tuberc Lung Dis,2001,5:589-593.
3Riska PF, Carleton S. Latent tuberculosis: models, mechanisms,and novel prospects for eradication. Semin Pediatr Infect Dis, 2002,13 : 263-272.
4Phyu S, Mustafa T, Hofstad T, et al. A mouse model for latent tuberculosis. Scand J Infect Dis, 1998, 30:59-68.
5de Wit D, Wootton M, Dhillon J, et al. The bacterial DNA content of mouse organs in the Comell model of dormant tuberculosis. Tuber Lung Dis,1995,76:555-562.
6Orme IM. A mouse model of the recrudescence of latent tuberculosis in the elderly. Am Rev Respir Dis, 1988,137:716-718.
7Howard AD, Trask OJ, Weisbrode SE, et al. Phenotypic changes in T cell populations during the reactivation of tuberculosis in mice.Clin Exp Immunol, 1998, 111:309-315.
8Howard AD, Zwilling BS. Cytokine production by CD4 and CD8 T cells during the growth of Mycobacterium tuberculosis in mice. Clin Exp Immunol, 1998, 113:443-449.
9Howard AD, Zwilling BS. Reactivation of tuberculosis is associated with a shift from type 1 to type 2 cytokines. Clin Exp Immunol,1999, 115:428-434.
10Flynn JL, Scanga CA, Tanaka KE, et al. Effects of aminoguanidine on latent murine tuberculosis. J Immunol, 1998,160:1796-1803.
